Triple-negative breast cancer (TNBC) is characterized by the absence of estrogen and progesterone receptors, and human epidermal growth factor receptor 2 (HER2) expression, and accounts for 15–20% of breast cancer cases [2]. Here, ERBB2 is linked to triple-negative breast carcinoma.